Risk factors for postoperative hypotension after adrenalectomy for phaeochromocytoma: derivation of the PACS risk score. Issue 2 (February 2023)
- Record Type:
- Journal Article
- Title:
- Risk factors for postoperative hypotension after adrenalectomy for phaeochromocytoma: derivation of the PACS risk score. Issue 2 (February 2023)
- Main Title:
- Risk factors for postoperative hypotension after adrenalectomy for phaeochromocytoma: derivation of the PACS risk score
- Authors:
- Parente, Alessandro
Thompson, Joseph P.
Crook, Charlotte
Bassett, Paul
Aspinall, Sebastian
Melvin, Ross
Stechman, Michael J.
Perry, Helen
Balasubramanian, Sabapathy P.
Pannu, Arslan
Palazzo, Fausto F.
Van Den Heede, Klaas
Eatock, Fiona
Anderson, Hannah
Doran, Helen
Wang, Kelvin
Hubbard, Johnathan
Aldrees, Abdulaziz
Shore, Susannah L.
Fung, Clare
Waghorn, Alison
Ayuk, John
Bennett, Davinia
Sutcliffe, Robert P. - Abstract:
- Abstract: Background: Due to the risk of postoperative hypotension (PH), invasive monitoring is recommended for patients who undergo adrenalectomy for phaeochromocytoma. Due to high costs and limited availability of intensive care, our aim was to identify patients at low risk of PH who may not require invasive monitoring. Methods: Data for patients who underwent adrenalectomy for phaeochromocytoma between 2012 and 2020 were retrospectively collected by nine UK centres, including patient demographics, intraoperative and postoperative haemodynamic parameters. Independent risk factors for PH were analysed and used to develop a clinical risk score. Results: PH developed in 118 of 430 (27.4%) patients. On univariable analysis, female sex (p = 0.007), tumour size (p < 0.001), preoperative catecholamine level (p < 0.001), open surgery (p < 0.001) and epidural analgesia (p = 0.006) were identified as risk factors for PH. On multivariable analysis, female sex (OR 1.85, CI95%, 1.09–3.13, p = 0.02), preoperative catecholamine level (OR: 3.11, CI95%, 1.74–5.55, p < 0.001), open surgery (OR: 3.31, CI95%, 1.57–6.97, p = 0.002) and preoperative mean arterial blood pressure (OR: 0.59, CI95%, 0.48–1.02, p = 0.08) were independently associated with PH, and were incorporated into a clinical risk score (AUROC 0.69, C-statistic 0.69). The risk of PH was 25% and 68% in low and high risk patients, respectively. Conclusion: The derived risk score allows stratification of patients at risk ofAbstract: Background: Due to the risk of postoperative hypotension (PH), invasive monitoring is recommended for patients who undergo adrenalectomy for phaeochromocytoma. Due to high costs and limited availability of intensive care, our aim was to identify patients at low risk of PH who may not require invasive monitoring. Methods: Data for patients who underwent adrenalectomy for phaeochromocytoma between 2012 and 2020 were retrospectively collected by nine UK centres, including patient demographics, intraoperative and postoperative haemodynamic parameters. Independent risk factors for PH were analysed and used to develop a clinical risk score. Results: PH developed in 118 of 430 (27.4%) patients. On univariable analysis, female sex (p = 0.007), tumour size (p < 0.001), preoperative catecholamine level (p < 0.001), open surgery (p < 0.001) and epidural analgesia (p = 0.006) were identified as risk factors for PH. On multivariable analysis, female sex (OR 1.85, CI95%, 1.09–3.13, p = 0.02), preoperative catecholamine level (OR: 3.11, CI95%, 1.74–5.55, p < 0.001), open surgery (OR: 3.31, CI95%, 1.57–6.97, p = 0.002) and preoperative mean arterial blood pressure (OR: 0.59, CI95%, 0.48–1.02, p = 0.08) were independently associated with PH, and were incorporated into a clinical risk score (AUROC 0.69, C-statistic 0.69). The risk of PH was 25% and 68% in low and high risk patients, respectively. Conclusion: The derived risk score allows stratification of patients at risk of postoperative hypotension after adrenalectomy for phaeochromocytoma. Postoperatively, low risk patients may be managed on a surgical ward, whilst high risk patients should undergo invasive monitoring. … (more)
- Is Part Of:
- European journal of surgical oncology. Volume 49:Issue 2(2023)
- Journal:
- European journal of surgical oncology
- Issue:
- Volume 49:Issue 2(2023)
- Issue Display:
- Volume 49, Issue 2 (2023)
- Year:
- 2023
- Volume:
- 49
- Issue:
- 2
- Issue Sort Value:
- 2023-0049-0002-0000
- Page Start:
- 497
- Page End:
- 504
- Publication Date:
- 2023-02
- Subjects:
- Phaeochromocytoma -- Adrenal surgery -- Adrenalectomy -- Postoperative hypotension
Oncology -- Periodicals
Cancer -- Surgery -- Periodicals
Medical Oncology -- Periodicals
Neoplasms -- surgery -- Periodicals
Cancer -- Chirurgie -- Périodiques
Cancérologie -- Périodiques
Oncologie
Chirurgie (geneeskunde)
Electronic journals
Electronic journals -- Sciences
Electronic journals -- Medicine
Electronic journals
616.994059005 - Journal URLs:
- http://www.ejso.com/ ↗
http://www.sciencedirect.com/science/journal/07487983 ↗
http://www.clinicalkey.com/dura/browse/journalIssue/07487983 ↗
http://www.clinicalkey.com.au/dura/browse/journalIssue/0720048X ↗
http://firstsearch.oclc.org ↗
http://firstsearch.oclc.org/journal=0748-7983;screen=info;ECOIP ↗
http://www.elsevier.com/journals ↗
http://www.harcourt-international.com/journals ↗
http://www.idealibrary.com/cgi-bin/links/toc/ejso ↗ - DOI:
- 10.1016/j.ejso.2022.10.006 ↗
- Languages:
- English
- ISSNs:
- 0748-7983
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3829.745500
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 25948.xml